Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug
Fierce Biotech
Tue, 09/1/15 - 06:38 pm
Tags:
AbbVie, Bristol-Myers Squibb, FDA, elotuzumab, Multiple Myeloma
AbbVie scores one against FTC in pay-for-delay AndroGel suit
Fierce Pharma
Thu, 08/27/15 - 11:34 am
Tags:
AbbVie, FTC, Androgel, pay-for-delay
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
Tags:
JNJ, daratumumab, Multiple Myeloma, Kyprolis, Amgen, Genmab, elotuzumab, AbbVie, Bristol-Myers Squibb
White House urged to stop states' 'rationing' of hep C drugs
Fierce Pharma
Wed, 08/26/15 - 11:56 am
Tags:
hepatitis C, Medicaid, Harvoni, Gilead Sciences, AbbVie, Viekira Pak
Who should Allergan buy next?
Fierce Pharma
Tue, 08/25/15 - 02:10 pm
Tags:
Allergan, M&A, AbbVie, Shire, Amgen, Biogen
Gilead Sciences, Inc. Harvoni Vs. AbbVie Inc Humira: Which Would Be Best-Selling Drug Of 2015?
Bidness, ETC
Tue, 08/25/15 - 08:56 am
Tags:
Gilead Sciences, Harvoni, AbbVie, Humira
AbbVie could end up sidestepping lost sales tied to an expiring patent on Humira in 2017
Motley Fool
Sun, 08/23/15 - 11:40 am
Tags:
AbbVie, Humira, patents, Imbruvica, autoimmune disease
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle
Seeking Alpha
Sat, 08/22/15 - 08:53 am
Tags:
spinoffs, AbbVie, Abbott Labs, Baxalta, Baxter
Why Four Months Is Worth $350m To AbbVie And Filgotinib
Seeking Alpha
Fri, 08/21/15 - 05:19 pm
Tags:
AbbVie, filgotinib, FDA, review vouchers, priority review
Did AbbVie Just Make an Incredibly Brilliant Decision?
Motley Fool
Fri, 08/21/15 - 09:31 am
Tags:
AbbVie, priority review, review vouchers, United Therapeutics
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
Tags:
AbbVie, priority review, Roche, CLL, chronic lymphocytic leukemia, United Therapeutics
AbbVie buys special review voucher for $350 mln
Yahoo/Reuters
Wed, 08/19/15 - 12:25 pm
Tags:
AbbVie, priority review, review vouchers, United Therapeutics
4 Top Pharma Stocks That Should Outperform Out To 2016
24/7 Wall St
Tue, 08/18/15 - 09:44 am
Tags:
AbbVie, Bristol-Myers Squibb, Eli Lilly, Merck
AbbVie Challenges Fairness Of Upcoming Testosterone Trials
Forbes
Mon, 08/17/15 - 07:18 pm
Tags:
AbbVie, testosterone, Androgel
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
Tags:
AbbVie, Amgen, biosimilars, JNJ, Sandoz, Novartis, Humira, Neupogen, Remicade, Nuelasta, Enbrel, epoetin-alfa
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Tags:
Galapagos, AbbVie, JAK inhibitors, rheumatoid arthritis, filgotinib
AbbVie Inc Cancer Drug Holds Blockbuster Potential
Bidness, ETC
Wed, 08/12/15 - 10:11 pm
Tags:
AbbVie, CLL, Roche, venetoclax
AbbVie to seek FDA approval for leukemia drug after trial success
Yahoo/Reuters
Wed, 08/12/15 - 10:35 am
Tags:
AbbVie, FDA, Roche, chronic lymphocytic leukemia, CLL, venetoclax
Why AbbVie Should Be Worth 25 Percent More
24/7 Wall St
Mon, 08/10/15 - 09:20 pm
Tags:
AbbVie
Galapagos peaks as AbbVie hype builds, Shorts target Bavarian, MorphoSys makes GPCR play
Fierce Biotech
Fri, 08/7/15 - 10:44 am
Tags:
Galapagos, AbbVie, Bavarian Nordic, Intec Pharma, MorphoSys

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.